| Financial Year |
March 31 2023 |
| Monetary Funds |
4,258,694,433.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
378,380,086.75 |
| Accounts Receivable |
604,537,322.58 |
| Advances to Suppliers |
212,518,653.74 |
| Other Receivables |
8,448,979.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,668,752,999.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,435,696.32 |
| Total Current Assets |
9,801,412,606.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,101,075.35 |
| Investment Properties |
23,934,721.38 |
| Fixed Assetes |
14,070,681,608.52 |
| Under-construction Projects |
493,121,361.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,093,865,240.05 |
| R&D expenses |
-- |
| Goodwill |
2,391,911.11 |
| Long-Term Deferred and Prepaid Expenses |
7,388,420.29 |
| Deferred Income Tax Assets |
855,972,493.34 |
| Other Non-Current Assets |
187,239,704.36 |
| Sub-Total of Non-Current Assets |
17,413,396,723.24 |
| Total Assets |
27,214,809,329.88 |
| Short-Term Loans |
606,723,517.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
940,625,905.49 |
| Accounts Payable |
2,406,824,339.63 |
| Accounts Received In Advance |
59,972,528.74 |
| Employee Compensation Payable |
449,937,881.81 |
| Taxes Payable |
178,572,253.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
259,700,335.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,488,057,130.91 |
| Other Current Liabilities |
284,126,320.30 |
| Sub-Total of Current Liabilities |
7,976,799,310.84 |
| Long-term Loans |
2,436,304,874.40 |
| Bonds Payable |
909,808,621.85 |
| Long-Term Accounts Payable |
1,710,344.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
51,176,419.27 |
| Deferred Income Tax Liabilities |
289,931,897.79 |
| Other Non-Current Liabilities |
12,043.96 |
| Sub-Total of Non-Current Liabilities |
4,654,535,348.88 |
| Total Liabilities |
12,631,334,659.72 |
| Paid-In Capital(Or Share Stock) |
2,064,349,448.00 |
| Capital Surplus |
3,545,002,686.27 |
| Surplus Reserve |
723,051,136.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,804,262,503.62 |
| Minority Stockholder's Interest |
1,399,006,580.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,184,468,089.18 |
| Owner's Equity（Stockholder's Equity） |
14,583,474,670.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,214,809,329.88 |
